Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
about
Pharmacokinetics and pharmacodynamics of antibacterial agents.Evaluation of ceftaroline activity versus ceftriaxone against clinical isolates of Streptococcus pneumoniae with various susceptibilities to cephalosporins in an in vitro pharmacokinetic/pharmacodynamic model.Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model.Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
P2860
Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Linezolid, levofloxacin, and v ...... n vitro pharmacodynamic model.
@en
Linezolid, levofloxacin, and v ...... n vitro pharmacodynamic model.
@nl
type
label
Linezolid, levofloxacin, and v ...... n vitro pharmacodynamic model.
@en
Linezolid, levofloxacin, and v ...... n vitro pharmacodynamic model.
@nl
prefLabel
Linezolid, levofloxacin, and v ...... n vitro pharmacodynamic model.
@en
Linezolid, levofloxacin, and v ...... n vitro pharmacodynamic model.
@nl
P2093
P2860
P1433
P1476
Linezolid, levofloxacin, and v ...... n vitro pharmacodynamic model.
@en
P2093
Michael J Rybak
Raymond Cha
Ronda L Akins
P2860
P304
P356
10.1592/PHCO.23.15.1531.31964
P407
P577
2003-12-01T00:00:00Z